Project AnimalAid commemorates World Animal Day

Celebrating compassion, sustainability and global care for animals In recognition of World Animal Day, Project AnimalAid, a Boulder-based 501(c)(3) nonprofit, is reaffirming its mission to improve animal health and promote environmental sustainability through collaboration and resource redistribution. https://mma.prnewswire.com/media/2788484/Project_AnimalAid__Logo.jpg World Animal Day is an international day of action celebrated annually on Oct. 4 to raise awareness

Prime Day Extravaganza: UWANT D100 Wet & Dry Vacuum Cleaner Launches with Exclusive Deals on Amazon

This Amazon Prime Day, theUWANT D100 Wet & Dry Vacuum Cleaner is available at a special promotional price on Amazon. Designed for families who value efficiency and comfort, the D100 not only effortlessly handles both wet and dry messes but also addresses a common issue with traditional cleaners-unpleasant odors-delivering a truly fresh and healthy home

ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation – MLTX

NEW YORK CITY, NY / ACCESS Newswire / October 4, 2025 / WHY: New York, N.Y., October 4, 2025. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MoonLake Immunotherapeutics (NASDAQ:MLTX) resulting from allegations that MoonLake may have issued materially misleading business information

Closer Campus Reports Record Growth and Expansion

NEW YORK CITY, NY / ACCESS Newswire / October 4, 2025 / Vienna, Austria – Closer Campus, founded by CEO Christoph Kauf, has announced a major expansion of its innovative sales training and job placement model. With the goal of helping over 1,000 individuals worldwide achieve career freedom by 2026, the Vienna-based platform has already

Peter Drage Launches MD Strategy Group for M&A Success

GRAZ, AUSTRIA, NY / ACCESS Newswire / October 4, 2025 / In an M&A market increasingly defined by complexity and volatility, a new advisory firm is launching with a model that prioritises strategic alignment and post-deal integration from day one. MD Strategy Group, co-founded by Austrian executive Peter Drage and Czech business leader Tomas Mrkvica,

MLTX LEGAL NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Investigation due to Drug Trial Results – Contact BFA Law if You Lost Money

(NASDAQ:MLTX), NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ: MLTX) for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics. Why Is MoonLake being Investigated? MoonLake

KMX LEGAL NOTICE: CarMax, Inc. Faces Securities Fraud Investigation due to Demand Issues – Contact BFA Law if You Lost Money

(NYSE:KMX), NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CarMax, Inc. (NYSE: KMX) for potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action. Why Is CarMax being Investigated? CarMax

CHTR LEGAL NOTICE: Charter Communications, Inc. Faces Securities Fraud Class Action due to Customer Decline – Contact BFA Law if You Lost Money

(NASDAQ:CHTR), NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Charter, you are encouraged to

MLTX LEGAL NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Investigation due to Drug Trial Results – Contact BFA Law if You Lost Money

MLTX LEGAL NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Investigation due to Drug Trial Results – Contact BFA Law if You Lost Money GlobeNewswire October 04, 2025 NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ: MLTX) for potential violations of

Scroll to Top